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Some medical applications are associated with high doses to the extremities of the staff exposed to ionising radiation. At
workplaces in nuclear medicine, interventional radiology, interventional cardiology and brachytherapy, extremities can be the
limiting organs as far as regulatory dose limits for workers are concerned. However, although the need for routine extremity
monitoring is clear for these applications, no data about the status of routine extremity monitoring reported by different
countries was collected and analysed so far, at least at a European level. In this article, data collected from seven European
countries are presented. They are compared with extremity doses extracted from dedicated studies published in the literature
which were reviewed in a previous publication. The analysis shows that dedicated studies lead to extremity doses signiﬁcantly
higher than the reported doses, suggesting that either the most exposed workers are not monitored, or the dosemeters are not
routinely worn or not worn at appropriate positions.
INTRODUCTION
According to the Council Directive 96/29/EURATOM
of the European Union(1), which is based on the rec-
ommendations of the ICRP(2), if the dose to any part
of the extremities of a worker is likely to exceed three-
tenths of the annual dose limit, an additional dose-
meter should be worn on the part of the extremity
where the dose is expected to have its highest value.
In practice, extremity monitoring is carried out by
measuring the personal dose equivalent Hp(0.07)
(3),
considering it as an estimator of the equivalent dose
to the skin for which the annual limit is 500 mSv.
The requirement of ﬁnding the area of skin where
the dose is maximum is one of the main problems
of extremity monitoring and causes severe practical
difﬁculties. In daily practice, when preparing and
administering radiopharmaceuticals in nuclear medi-
cine (NM), or participating in a complex radiological
intervention in interventional radiology/interven-
tional cardiology (IR/IC), it is not easy to know
which part of the hand will receive the highest dose.
Moreover, the dose distribution across the hand may
vary during a single process as well as when various
persons perform the same procedure. Another
difﬁculty is that the dosemeter should not disturb
manipulations carried out by the medical staff, it has
to be compatible with the wearing of gloves and, if
needed, with sterilisation protocols. Also, the dose-
meter has to be adapted to the encountered radiation
ﬁelds. For these reasons extremities, and particularly
hands, are difﬁcult to monitor.
The objective of EURADOS Working Group 9
(WG9) (funded by the European Commission,
through the CONRAD project) was to promote and
coordinate research activities for the assessment of
occupational exposures to medical staff. Sub-group 1
(SG1) of WG9 dealt with extremity dosimetry of
workers in IR, IC, NM and brachytherapy (BT).
These activities involve either the direct handling of
highly active X, g or bþ/2 sources (e.g. 99mTc, 201Tl,
131I, 18F, 90Y in NM, 192Ir, 137Cs in BT), or working
close to an X-ray radiation ﬁeld (typically 60–100 kV
ﬁltered X-rays in IR and IC).
The tasks undertaken by SG1 were to perform (i) an
intercomparison of relevant extremity dosimetry tech-
niques; (ii) a thorough literature review of dedicated
studies; and (iii) an overview of the use of extremity
dosemeters in some European countries. The results of
the intercomparison and the literature review have
been published(4,5), see also reference(6). This article
deals with the third task, the dosimetric data overview.
Data related to the use of extremity dosemeters in
the medical ﬁeld were collected from seven countries.
They are presented and compared with the doses
extracted from the literature review.*Corresponding author: laurent.donadille@irsn.fr
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METHOD
Extremity dosimetry data were collected from seven
countries: Switzerland, Germany, Spain, France,
Greece, Ireland and Poland. They were provided by
the central register of each country, except for France
and Poland. The data for France have been obtained
from different dosimetry services, nevertheless repre-
senting all monitored workers. For Poland, they come
from one dosimetry service, representing the majority
of the workers monitored for extremities.
The development of extremity dosimetry has been
substantially different in the seven chosen countries.
As regards, the position and type of dosemeter
(Table 1), Spain and France perform extremity
dosimetry using wrist or ring dosemeters, depending
on the dosimetry service. Nevertheless wrist dose-
meters are more widely used than ring ones in these
two countries. Switzerland, Germany, Ireland and
Poland only use ring dosemeters, whereas in Greece,
wrist dosemeters were used until 2006 and from 2007
ring dosemeters have been introduced. The monitor-
ing period is 1 month for all seven countries. As
mentioned earlier, the dosemeter should be placed at
the position where the highest value is expected.
However, in practice this is not done and often even
not possible. In general, the wrist dosemeter is worn
at wrist level on one of the two arms, but there is no
recommendation about which of the two arms is to
be monitored, nor is there on the orientation of the
dosemeter. Differences in position are even larger in
the case of ring dosemeters, since each user decides
which ﬁnger the dosemeter is worn on and the orien-
tation with respect to the radiation source.
The data were classiﬁed into three categories of
medical applications: IR/IC, NM and radiation
therapy (TH). In general, the group of IR/IC includes
any use of X-rays in diagnostics and therapy, with
and without ﬂuoroscopy. The group of NM includes
workers in conventional diagnostic NM, position
emission tomography (PET), therapy with unsealed
pharmaceuticals and radiopharmaceutical units. TH
involves workers in BT and therapy. However, one has
to keep in mind that it is difﬁcult to unambiguously
identify these three different activities from the col-
lected information because, for example, each dosim-
etry service has its own labelling method of its
customers (workers) which does not strictly correspond
to our classiﬁcation. Besides, it was not possible to dis-
tinguish between diagnostic and therapeutic NM since
most of NM departments have a single subscription to
routine extremity dosimetry for both activities.
Another parameter on which there is no consen-
sus is the reporting level. In Switzerland, Germany,
Greece and Poland, the reporting level is 1 mSv,
whereas in Ireland and Spain it is 0.1 mSv, and
between 0.1 and 0.3 mSv for France, depending on
the dosimetry service. These differences inﬂuence the
numerical value of the reported mean doses to the
exposed workers.
These examples conﬁrm that there is a need for
harmonisation of dosimetric practices in extremity
monitoring across Europe(7).
In all cases, the reported mean doses were calculated
for monitored workers. Of course, the values would
have been higher if they had been given for exposed
workers (those with doses larger than zero) and, in
both cases, they are inﬂuenced by the reporting level
value. In Germany, the exposed workers represent
about 25% of the monitored workers for IR and 50%
of NM workers. In Spain, the exposed workers are
60% of those monitored for IR and 85% for NM.
RESULTS AND DISCUSSION
Extremity dosimetry in the medical ﬁeld
Table 1 shows, for year 2005, the number of moni-
tored workers in the medical ﬁeld in the seven chosen
European countries (rounded numbers), together with
the fraction who use extremity dosemeters, detailing
the type of dosemeter used. French data include
veterinary workers, who represent 6.7% of the total.
Most monitored workers in the medical ﬁeld wear a
Table 1. Summary of individual monitoring in the medical ﬁeld for seven European countries in 2005: France (F), Germany
(D), Greece (GR), Ireland (IE), Poland (PL) Spain (E) and Switzerland (CH).





Ring dosemeter Wrist dosemeter
F 159 000a 5 19 81
D 240 000 5 100 0
GR 9200 2 0 100
IE 6900 5 100 0
PL 29 200 2 100 0
E 43 000 9 5 95
CH 50 800 2 100 0
aIncluding veterinary workers, who represent 6.7% of the total.
USE OF EXTREMITY DOSEMETERS FOR MEDICAL APPLICATIONS
63
whole body dosemeter. However, only a minority,
between 2 and 9%, also wear an extremity dosemeter.
Reported extremity doses
The following paragraphs present the registered
mean extremity doses classiﬁed for the three medical
applications (IR/IC, NM and TH) considered and
the type of dosemeters (ring and wrist) used.
Although better statistical indicators than the mean
doses would be the variability range (minimum and
maximum doses) and the median value in each case,
these were not provided in the collected data.
Interventional radiology/cardiology
Table 2 presents the mean annual extremity doses in
IR/IC, for year 2005. Mean doses is range from 2.5
to 19.2 mSv. In the countries where both ring and
wrist dosimetry are used, mean annual doses
measured with a ring dosemeter are always higher
than those obtained with a wrist dosemeter, differ-
ences are a factor of 2 and 7 for Spain and France,
respectively. For Greece, the large wrist annual dose
is due to two cases of bad practices and is reduced
to 1.85 mSv if they are not considered. The second
part of the table indicates the number of workers
with a mean annual dose higher than 5 mSv and
those with a dose higher than 50 mSv for the
countries which these data were available from. The
percentage of monitored workers which represents
each category is shown beside. It can be seen that
annual extremity doses above 50 mSv are found in
very few cases only.
Nuclear medicine
Table 3 gives the mean annual extremity doses in
NM, for year 2005. Likewise in Table 2, the number
of workers receiving doses higher than 5 and 50 mSv
is shown. For Germany, the classiﬁcation has to be
interpreted in a different way: the number of workers
with doses higher than 5 mSv (50 mSv) actually cor-
responds to the number with doses higher than
1 mSv (10 mSv). The reported mean annual doses in
NM range from 1.9 to 29.1 mSv. In the countries in
which both ring and wrist dosemeters are used,
mean annual doses measured with a ring dosemeter
are about four times higher than those obtained
with a wrist one. Again, the number of workers with
annual doses above 50 mSv is very small.
When comparing the mean doses derived from
ring dosemeters for NM with those of IR/IC for the
same country, it can be observed that the mean
doses are higher for NM than for IR/IC.
Radiation therapy
There are very few data available for the extremity
doses due to TH. Table 4 presents the mean annual
extremity doses in TH for France, Germany and
Ireland for year 2005, together with the number of
workers receiving doses higher than 5 and 50 mSv in
this medical ﬁeld. As mentioned earlier for Germany,
this classiﬁcation is different. Reported mean annual
doses are between 2 and 8 mSv for ring dosemeters
and 1.4 mSv for wrist dosemeters. In France, where
both ring and wrist dosemeters are used, mean
annual doses measured with a ring dosemeter are
about six times higher than those with a wrist one.
Comparison with data from literature
dedicated studies
Several dedicated studies dealing with the evaluation
of extremity doses in different medical applications
were published in the literature. They have been
reviewed in a recent publication(5). This review















Ring F 1279 0.1–0.3 10.9 — —
D 7155 1 2.5 — —
IE 188 0.1 2.3 0 (0%) 0 (0%)
PL 585 1 8.2 — 0 (0%)
E 50 0.1 19.2 25 (50%) 10 (20%)
CH 407 1 3.6 39 (10%) 9 (2%)
Wrist F 5302 0.1–0.2 1.5 — —
GRa 133 1 17.9 7 (5%) 2 (2%)
E 2799 0.1 8.9 654 (23%) 144 (5%)
— indicates no data available.
a For Greece the mean annual dose is reduced to 1.85 mSv when two cases of bad-practices are not considered.
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notably highlighted the fact that signiﬁcant extremity
doses can be reached. In IR/IC, most published
estimations of annual extremity doses led to levels
smaller than the dose limits, but some authors found
higher doses than limits. In conventional diagnostic
NM (i.e. scintigraphies carried out mainly with
99mTc), published extrapolations give a range of 4 to
more than 300 mSv per year. Some studies even
report annual extremity doses at the area of skin
where the maximum dose is up to a few Sv. Anyhow
annual extrapolations published in the literature
reached easily few tens to few hundreds mSv per year.
These observations are in apparent contradiction
with the annual reported doses from the seven
European countries considered previously. For
example, from Table 3, it is shown that the mean
annual ring doses range in 5–30 mSv, with only few
cases presenting doses larger than 50 mSv.
These discrepancies are probably due to the fact
that (i) the dosemeters may not be systematically
worn; (ii) the most exposed workers may not be
monitored; and (iii) the dosemeters may be worn at
not adapted positions, leading to signiﬁcant underes-
timations of the doses.
CONCLUSIONS
The increasing use of ionising radiation in medicine
requires the development of new radiation protection
programmes. Large differences between mean
annual doses reported in national dosimetric data
bases and dosimetry services, and measured doses in
pilot research studies are found. This shows that the
present extremity dose monitoring underestimates
the real radiological risk of exposed medical staff
and that no particular effort on the identiﬁcation of
the most exposed area is done. Nevertheless, the
mean values recorded with ring dosemeters indicate
that this kind of extremity dosemeters is a better esti-
mator of the maximum doses to the extremity than
wrist ones.
In spite of the difﬁculties involved in the routine
monitoring of extremities, the development of a
systematic study which could identify ‘the most
exposed area’ for typical or more common activities
could enable agreement on general requirements
that could be followed by most of the users, and
thus ensure adequate harmonisation within the EU
member states.















Ring F 314 0.1–0.3 12.2 — —
Da 3104 1 7.1 78 (3%) 46 (1%)
IE 111 0.1 5.7 34 (31%) 0 (0%)
PL 143 1 7.6 — 0 (0%)
E 129 0.1 29.1 75 (58%) 23 (18%)
CH 404 1 9 119 (29%) 19 (5%)
Wrist F 862 0.1–0.2 3.1 — —
GR 45 1 1.9 3 (7%) 0 (0%)
E 698 0.1 6.5 206 (30%) 11 (2%)
— indicates no data available.
aFor Germany, the number of workers with doses larger than 5 mSv (50 mSv), actually corresponds to number of workers
with doses larger than 1 mSv (10 mSv).















Ring F 24 0.1–0.3 8 — —
Da 544 1 2 5 (1%) 2 (0.4%)
IE 63 0.1 4.6 28 (44%) 0 (0%)
Wrist F 590 0.1–0.2 1.4 — —
aFor Germany, the number of workers with doses larger than 5 mSv (50 mSv), actually corresponds to number of workers
with doses larger than 1 mSv (10 mSv).
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Finally, it should be pointed out that it would be
very desirable to complete with extremity doses
general international individual monitoring data-
bases, such as UNSCEAR, ESOREX or ISOE.
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